14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ALXO stock ended at $15.36. This is 7.58% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.59% from a day low at $15.21 to a day high of $17.13.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical ALX Oncology Holdings Inc. prices

Date Open High Low Close Volume
Feb 22, 2024 $15.96 $16.29 $15.66 $16.05 144 055
Feb 21, 2024 $16.12 $16.26 $15.32 $15.86 210 568
Feb 20, 2024 $15.85 $16.34 $15.85 $16.25 258 938
Feb 16, 2024 $16.79 $16.79 $15.47 $15.85 290 724
Feb 15, 2024 $16.13 $17.42 $16.12 $16.79 508 387
Feb 14, 2024 $14.54 $16.00 $14.54 $15.84 268 524
Feb 13, 2024 $14.29 $14.58 $13.90 $14.16 201 060
Feb 12, 2024 $14.20 $15.00 $14.15 $14.99 230 979
Feb 09, 2024 $13.98 $14.23 $13.36 $14.06 317 191
Feb 08, 2024 $15.03 $15.14 $13.78 $13.82 411 713
Feb 07, 2024 $15.67 $15.67 $14.39 $15.05 342 446
Feb 06, 2024 $15.87 $16.00 $14.70 $15.64 317 600
Feb 05, 2024 $14.51 $15.78 $14.23 $15.65 499 444
Feb 02, 2024 $14.75 $14.91 $14.14 $14.70 333 917
Feb 01, 2024 $14.47 $15.19 $14.15 $15.00 288 193
Jan 31, 2024 $14.29 $14.72 $13.68 $14.41 272 430
Jan 30, 2024 $14.75 $14.75 $13.85 $14.41 259 066
Jan 29, 2024 $14.79 $15.20 $14.26 $14.97 217 824
Jan 26, 2024 $14.47 $14.79 $14.25 $14.74 134 816
Jan 25, 2024 $14.48 $15.09 $14.31 $14.48 204 751
Jan 24, 2024 $13.93 $14.53 $13.76 $14.21 172 136
Jan 23, 2024 $13.55 $13.84 $13.32 $13.59 191 419
Jan 22, 2024 $13.41 $13.68 $13.03 $13.36 195 942
Jan 19, 2024 $12.81 $13.33 $12.47 $13.31 218 859
Jan 18, 2024 $14.04 $14.04 $12.69 $12.76 340 411
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT